Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration
Staels and Fonseca
Diabetes Care 2009;32:S237-S245.
FULL TEXT
Genetic Determinants of Cardiovascular Disease: The Renin-Angiotensin-Aldosterone System, Paraoxonases, Endothelin-1, Nitric Oxide Synthase and Adrenergic Receptors
GLUBA et al.
In Vivo 2009;23:797-812.
ABSTRACT
| FULL TEXT
Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness
Piconi et al.
FASEB J. 2009;23:1196-1204.
ABSTRACT
| FULL TEXT
Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.
Robinson et al.
J Am Coll Cardiol 2009;53:316-322.
ABSTRACT
| FULL TEXT
Recognition and Management of Dyslipidemia in Children and Adolescents
Kwiterovich
J. Clin. Endocrinol. Metab. 2008;93:4200-4209.
ABSTRACT
| FULL TEXT
An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients
Pullinger et al.
J. Lipid Res. 2008;49:1846-1854.
ABSTRACT
| FULL TEXT
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
Guyton et al.
J Am Coll Cardiol 2008;51:1564-1572.
ABSTRACT
| FULL TEXT
Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required
Superko and King
Circulation 2008;117:560-568.
FULL TEXT
New Technology for Noninvasive Evaluation of Coronary Artery Disease
Di Carli and Hachamovitch
Circulation 2007;115:1464-1480.
FULL TEXT
Rational therapy of mixed dyslipidaemia in a patient with diabetes
Reasner
British Journal of Diabetes & Vascular Disease 2007;7:25-30.
ABSTRACT
Niaspan(R) in the management of dyslipidaemia: the evidence
Brown
Eur Heart J Suppl 2006;8:F60-F67.
ABSTRACT
| FULL TEXT
Genetic variation of PLTP modulates lipoprotein profiles in hypoalphalipoproteinemia
Aouizerat et al.
J. Lipid Res. 2006;47:787-793.
ABSTRACT
| FULL TEXT
Perspectives on Dyslipidemia and Coronary Heart Disease in Women
Bittner
J Am Coll Cardiol 2005;46:1628-1635.
ABSTRACT
| FULL TEXT
Efficacy and Safety of Lovastatin Therapy in Adolescent Girls With Heterozygous Familial Hypercholesterolemia
Clauss et al.
Pediatrics 2005;116:682-688.
ABSTRACT
| FULL TEXT
Maximizing coronary disease risk reduction using nicotinic acid combined with LDL-lowering therapy
Brown
Eur Heart J Suppl 2005;7:F34-F40.
ABSTRACT
| FULL TEXT
Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL
Albert et al.
J. Lipid Res. 2005;46:469-474.
ABSTRACT
| FULL TEXT
Apolipoprotein E Promotes the Regression of Atherosclerosis Independently of Lowering Plasma Cholesterol Levels
Raffai et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:436-441.
ABSTRACT
| FULL TEXT
Modern intervention strategies for managing dyslipidaemia: the case for combination therapy
Drexel
British Journal of Diabetes & Vascular Disease 2005;5:S17-S23.
ABSTRACT
Addressing Cardiovascular Disease in Women: Focus on Dyslipidemia
Meagher
J Am Board Fam Med 2004;17:424-437.
ABSTRACT
| FULL TEXT
Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review
Austin et al.
Am J Epidemiol 2004;160:407-420.
ABSTRACT
| FULL TEXT
Flavonoid-Rich Dark Chocolate Improves Endothelial Function and Increases Plasma Epicatechin Concentrations in Healthy Adults
Engler et al.
J. Am. Coll. Nutr. 2004;23:197-204.
ABSTRACT
| FULL TEXT
A Pedigree Analysis of Familial Hypercholesterolemia in Monozygote Twin Brothers
Li et al.
ANGIOLOGY 2003;54:711-713.
ABSTRACT
Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial
Engler et al.
Circulation 2003;108:1059-1063.
ABSTRACT
| FULL TEXT
Regression of Carotid and Femoral Artery Intima-Media Thickness in Familial Hypercholesterolemia: Treatment With Simvastatin
de Sauvage Nolting et al.
Arch Intern Med 2003;163:1837-1841.
ABSTRACT
| FULL TEXT
Cardiovascular Endocrinology: Introduction
Baxter et al.
Endocr. Rev. 2003;24:253-260.
FULL TEXT
Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids
Aouizerat et al.
J. Lipid Res. 2003;44:1167-1173.
ABSTRACT
| FULL TEXT
Systematic Family Screening for Familial Hypercholesterolemia in Iceland
Thorsson et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:335-338.
ABSTRACT
| FULL TEXT
Long-term Compliance With Lipid-Lowering Medication After Genetic Screening for Familial Hypercholesterolemia
Umans-Eckenhausen et al.
Arch Intern Med 2003;163:65-68.
ABSTRACT
| FULL TEXT
Combination therapy: its rationale and the role of ezetimibe
Stone
Eur Heart J Suppl 2002;4:J19-J22.
ABSTRACT
Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL
Cheung et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:1320-1326.
ABSTRACT
| FULL TEXT
Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia
Bhatnagar et al.
BMJ 2000;321:1497-1497.
ABSTRACT
| FULL TEXT
Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis : The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)
Teo et al.
Circulation 2000;102:1748-1754.
ABSTRACT
| FULL TEXT
Recommendations for the management and treatment of dyslipidemia: Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias
Fodor et al.
CMAJ 2000;162:1441-1447.
FULL TEXT
Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury
Indolfi et al.
J Am Coll Cardiol 2000;35:214-221.
ABSTRACT
| FULL TEXT
Preventing Coronary Artery Disease by Lowering Cholesterol Levels: Fifty Years From Bench to Bedside
Steinberg and Gotto
JAMA 1999;282:2043-2050.
ABSTRACT
| FULL TEXT
Drug Treatment of Lipid Disorders
Knopp
NEJM 1999;341:498-511.
FULL TEXT
Long-Term Follow-Up After Percutaneous Transluminal Coronary Angioplasty Was Not Performed Based on Intravascular Ultrasound Findings : Importance of Lumen Dimensions
Abizaid et al.
Circulation 1999;100:256-261.
ABSTRACT
| FULL TEXT
Effects of Lovastatin and Warfarin on Early Carotid Atherosclerosis : Sex-Specific Analyses
Byington et al.
Circulation 1999;100
:e14-e17.
ABSTRACT
| FULL TEXT
Improvement of Impaired Myocardial Vasodilatation Due to Diffuse Coronary Atherosclerosis in Hypercholesterolemics After Lipid-Lowering Therapy
Yokoyama et al.
Circulation 1999;100:117-122.
ABSTRACT
| FULL TEXT
Aggressive Cholesterol Lowering Delays Saphenous Vein Graft Atherosclerosis in Women, the Elderly, and Patients With Associated Risk Factors : NHLBI Post Coronary Artery Bypass Graft Clinical Trial
Campeau et al.
Circulation 1999;99:3241-3247.
ABSTRACT
| FULL TEXT
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile
Dangas et al.
J Am Coll Cardiol 1999;33:1294-1304.
ABSTRACT
| FULL TEXT
Forecasting Patient Outcomes in the Management of Hyperlipidemia
Brier et al.
Arch Intern Med 1999;159:569-575.
ABSTRACT
| FULL TEXT
Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions
Bucher et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:187-195.
ABSTRACT
| FULL TEXT
Strategies to achieve coronary arterial plaque stabilization
Rabbani and Topol
Cardiovasc Res 1999;41:402-417.
ABSTRACT
| FULL TEXT
Efficacy and Safety of Lovastatin in Adolescent Males With Heterozygous Familial Hypercholesterolemia: A Randomized Controlled Trial
Stein et al.
JAMA 1999;281:137-144.
ABSTRACT
| FULL TEXT
Present Status of HMG Reductase Inhibitors in Treatment of Dyslipidemia
Kalmansohn et al.
ANGIOLOGY 1998;49:801-805.
ABSTRACT
Joint British recommendations on prevention of coronary heart disease in clinical practice
British Cardiac Society et al.
Heart 1998;80:1S-29.
FULL TEXT
Effective Lipid Modification by Partial Ileal Bypass Reduced Long-term Coronary Heart Disease Mortality and Morbidity: Five-Year Posttrial Follow-up Report From the POSCH
Buchwald et al.
Arch Intern Med 1998;158:1253-1261.
ABSTRACT
| FULL TEXT
Angiotensin-Converting Enzyme DD Genotype and Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia
O'Malley et al.
Circulation 1998;97:1780-1783.
ABSTRACT
| FULL TEXT
Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis : Results of the LIPID Atherosclerosis Substudy
MacMahon et al.
Circulation 1998;97:1784-1790.
ABSTRACT
| FULL TEXT
IDL Composition and Angiographically Determined Progression of Atherosclerotic Lesions During Simvastatin Therapy
Sutherland et al.
Arterioscler. Thromb. Vasc. Bio. 1998;18:577-583.
ABSTRACT
| FULL TEXT
Treating Hyperlipidemia for the Primary Prevention of Coronary Disease: Are Higher Dosages of Lovastatin Cost-effective?
Perreault et al.
Arch Intern Med 1998;158:375-381.
ABSTRACT
| FULL TEXT
Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol
Frick et al.
Circulation 1997;96:2137-2143.
ABSTRACT
| FULL TEXT
Simvastatin Reduces Graft Vessel Disease and Mortality After Heart Transplantation : A Four-Year Randomized Trial
Wenke et al.
Circulation 1997;96:1398-1402.
ABSTRACT
| FULL TEXT
Adherence to National Cholesterol Education Program Treatment Goals in Postmenopausal Women With Heart Disease: The Heart and Estrogen/Progestin Replacement Study (HERS)
Schrott et al.
JAMA 1997;277:1281-1286.
ABSTRACT
Treatment of Hypercholesterolemia in Women: Equality, Effectiveness, and Extrapolation of Evidence
Pearson and Myerson
JAMA 1997;277:1320-1321.
ABSTRACT
Patients' Attitudes Toward Detection of Heterozygous Familial Hypercholesterolemia
Andersen et al.
Arch Intern Med 1997;157:553-560.
ABSTRACT
Single-strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hypercholesterolemia
Humphries et al.
Clin. Chem. 1997;43:427-435.
ABSTRACT
| FULL TEXT
Hypobetalipoproteinemia Is Associated With Low Levels of Hemostatic Risk Factors in the Framingham Offspring Population
Welty et al.
Circulation 1997;95:825-830.
ABSTRACT
| FULL TEXT
The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts
The Post Coronary Artery Bypass Graft Trial Invest
NEJM 1997;336:153-163.
ABSTRACT
| FULL TEXT
Cerivastatin, a New Potent Synthetic HMG Co-A Reductase Inhibitor: Effect of 0.2 mg Daily in Subjects With Primary Hypercholesterolemia
Stein et al.
J CARDIOVASC PHARMACOL THER 1997;2:7-16.
ABSTRACT
Serum Lipids and Incidence of Coronary Heart Disease: Findings From the Systolic Hypertension in the Elderly Program (SHEP)
Frost et al.
Circulation 1996;94:2381-2388.
ABSTRACT
| FULL TEXT
Predominance of Dense Low-Density Lipoprotein Particles Predicts Angiographic Benefit of Therapy in the Stanford Coronary Risk Intervention Project
Miller et al.
Circulation 1996;94:2146-2153.
ABSTRACT
| FULL TEXT
Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis: A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy
Waters et al.
Circulation 1996;94:614-621.
ABSTRACT
| FULL TEXT
The Influence of Angiographic Endpoints on the Outcome of Lipid Intervention Studies: A Proposal for Standardization
Wouter Jukema et al.
ANGIOLOGY 1996;47:633-642.
ABSTRACT
Coronary Heart Disease Risk Factors in Men and Women Aged 60 Years and Older : Findings From the Systolic Hypertension in the Elderly Program
Frost et al.
Circulation 1996;94:26-34.
ABSTRACT
| FULL TEXT
Beyond Low-Density Lipoprotein Cholesterol: A Perspective on Low High-Density Lipoprotein Disorders and Lp(a) Lipoprotein Excess
Rosenson
Arch Intern Med 1996;156:1278-1284.
ABSTRACT
Meta-analysis, Clinical Trials, and Transferability of Research Results Into Practice: The Case of Cholesterol-Lowering Interventions in the Secondary Prevention of Coronary Heart Disease
Marchioli et al.
Arch Intern Med 1996;156:1158-1172.
ABSTRACT
Effectiveness of Low-Dose Crystalline Nicotinic Acid in Men With Low High-Density Lipoprotein Cholesterol Levels
Martin-Jadraque et al.
Arch Intern Med 1996;156:1081-1088.
ABSTRACT
LDL-Apheresis Atherosclerosis Regression Study (LAARS) : Effect of Aggressive Versus Conventional Lipid Lowering Treatment on Coronary Atherosclerosis
Kroon et al.
Circulation 1996;93:1826-1835.
ABSTRACT
| FULL TEXT
Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women
Guetta and Cannon
Circulation 1996;93:1928-1937.
FULL TEXT
Atherosclerosis and Risk Factor Modification: Does It Really Make a Difference?
Corson et al.
PERSPECT VASC SURG ENDOVASC THER 1996;9:75-94.
Progression of Coronary Artery Disease Predicts Clinical Coronary Events : Long-term Follow-up From the Cholesterol Lowering Atherosclerosis Study
Azen et al.
Circulation 1996;93:34-41.
ABSTRACT
| FULL TEXT
Hyperlipidemia and Coronary Disease : Correction of the Increased Thrombogenic Potential With Cholesterol Reduction
Lacoste et al.
Circulation 1995;92:3172-3177.
ABSTRACT
| FULL TEXT
Reducing Low-Density Lipoprotein Cholesterol Levels in an Ambulatory Care System: Results of a Multidisciplinary Collaborative Practice Lipid Clinic Compared With Traditional Physician-Based Care
Shaffer and Wexler
Arch Intern Med 1995;155:2330-2335.
ABSTRACT
Effects of Cholesterol Lowering on the Progression of Coronary Atherosclerosis in Women : A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy
Waters et al.
Circulation 1995;92:2404-2410.
ABSTRACT
| FULL TEXT
Treatment of Hyperlipidemia in Women
Walsh and Grady
JAMA 1995;274:1152-1158.
ABSTRACT
Kuopio Atherosclerosis Prevention Study (KAPS) : A Population-Based Primary Preventive Trial of the Effect of LDL Lowering on Atherosclerotic Progression in Carotid and Femoral Arteries
Salonen et al.
Circulation 1995;92:1758-1764.
ABSTRACT
| FULL TEXT
Efficacy and Safety of Pravastatin in African Americans With Primary Hypercholesterolemia
Jacobson et al.
Arch Intern Med 1995;155:1900-1906.
ABSTRACT
Changes in Myocardial Perfusion Abnormalities by Positron Emission Tomography After Long-term, Intense Risk Factor Modification
Gould et al.
JAMA 1995;274:894-901.
ABSTRACT
Effect of Pravastatin on Outcomes after Cardiac Transplantation
Kobashigawa et al.
NEJM 1995;333:621-627.
ABSTRACT
| FULL TEXT
Lipid Lowering, Regression, and Coronary Events : A Review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council Meeting
Gotto
Circulation 1995;92:646-656.
FULL TEXT
The Primary Prevention of Coronary Heart Disease in Women
Rich-Edwards et al.
NEJM 1995;332:1758-1766.
FULL TEXT
Management of Primary Hyperlipidemia
Havel and Rapaport
NEJM 1995;332:1491-1498.
FULL TEXT
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels : The Regression Growth Evaluation Statin Study (REGRESS)
Jukema et al.
Circulation 1995;91:2528-2540.
ABSTRACT
| FULL TEXT
Cholesterol Reduction in Cardiovascular Disease -- Clinical Benefits and Possible Mechanisms
Levine et al.
NEJM 1995;332:512-521.
FULL TEXT
Coronary artery bypass grafting in familial hypercholesterolemia
Kawasuji et al.
J. Thorac. Cardiovasc. Surg. 1995;109:364-369.
ABSTRACT
| FULL TEXT
Risk Factors That Attenuate the Female Coronary Disease Advantage
Kannel and Wilson
Arch Intern Med 1995;155:57-61.
ABSTRACT
Efficacy and Safety of Once-Daily vs Twice-Daily Dosing With Fluvastatin, a Synthetic Reductase Inhibitor, in Primary Hypercholesterolemia
Insull et al.
Arch Intern Med 1994;154:2449-2455.
ABSTRACT
Psyllium for the Reduction of Cholestyramine-Associated Gastrointestinal Symptoms in the Treatment of Primary Hypercholesterolemia
Maciejko et al.
Arch Fam Med 1994;3:955-960.
ABSTRACT
A Comparison of the Efficacy and Toxic Effects of Sustained- vs Immediate-Release Niacin in Hypercholesterolemic Patients
McKenney et al.
JAMA 1994;271:672-677.
ABSTRACT
Reversal of Gangrenous Lesions in the Blue Toe Syndrome with Lovastatin A Case Report
Cabili et al.
ANGIOLOGY 1993;44:821-825.
ABSTRACT
Compliance With Childhood Cholesterol Screening Among Members of a Prepaid Health Plan
Bachman et al.
Arch Pediatr Adolesc Med 1993;147:382-385.
ABSTRACT
Preventive Medicine for Our Ailing Health Care System
Leaf
JAMA 1993;269:616-618.
ABSTRACT
Changes in Sequential Coronary Arteriograms and Subsequent Coronary Events
Buchwald et al.
JAMA 1992;268:1429-1433.
ABSTRACT
Comparison of Gemfibrozil and Lovastatin in Patients With High Low-Density Lipoprotein and Low High-Density Lipoprotein Cholesterol Levels
McKenney et al.
Arch Intern Med 1992;152:1781-1787.
ABSTRACT
Blood Lipid Measurements: Variations and Practical Utility
Cooper et al.
JAMA 1992;267:1652-1660.
ABSTRACT
Serum Cholesterol as a Prognostic Factor after Myocardial Infarction
Goldstein
ANN INTERN MED 1992;116:425-426.
ABSTRACT
What If Americans Ate Less Fat?
Ornish
JAMA 1992;267:362-362.
ABSTRACT
